Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;111:2820-2827
Published online before print May 23, 2005, doi: 10.1161/CIRCULATIONAHA.104.502617
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
111/21/2820    most recent
CIRCULATIONAHA.104.502617v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stawowy, P.
Right arrow Articles by Graf, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stawowy, P.
Right arrow Articles by Graf, K.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Related Collections
Right arrow Other Vascular biology
Right arrow Pathophysiology
Right arrow Gene expression

(Circulation. 2005;111:2820-2827.)
© 2005 American Heart Association, Inc.


Vascular Medicine

Furin-Like Proprotein Convertases Are Central Regulators of the Membrane Type Matrix Metalloproteinase–Pro-Matrix Metalloproteinase-2 Proteolytic Cascade in Atherosclerosis

Philipp Stawowy, MD; Heike Meyborg, MSc; Dietger Stibenz, PhD; Núbia Borges Pereira Stawowy, DMD; Mattias Roser, MD; Usan Thanabalasingam, MD; John P. Veinot, MD; Michel Chrétien, MD; Nabil G. Seidah, PhD; Eckart Fleck, MD; Kristof Graf, MD

From the Department of Medicine/Cardiology, Deutsches Herzzentrum Berlin, Berlin, Germany (P.S., H.M., D.S., N.B.P.S., M.R., U.T., E.F., K.G.); Diseases of Aging and Regional Protein Chemistry Centers, Ottawa Health Research Institute, University of Ottawa, Ottawa, Ontario, Canada (J.P.V., M.C.); and Laboratory of Biochemical Neuroendocrinology, Clinical Research Institute, Montréal, Quebec, Canada (N.G.S.).

Correspondence to Dr Philipp Stawowy, Department of Medicine/Cardiology, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, D-13353 Berlin, Germany. E-mail stawowy{at}dhzb.de

Received August 25, 2004; revision received December 23, 2004; accepted January 19, 2005.

Background— Accumulation of macrophages and their in situ expression of matrix metalloproteinases (MMPs) are important determinants of plaque stability. Activation of membrane-bound MT1-MMP, the major activator of pro-MMP-2, requires intracellular endoproteolytic cleavage of its precursor protein. This type of activation typically requires suitable furin-like proprotein convertases (PCs), specifically furin and PC5. The present study was done to investigate the function of MT1-MMP as well as furin-like PCs in mononuclear inflammatory cells.

Methods and Results— Macrophage differentiation of human monocytic THP-1 cells was accompanied by increased expression of furin, PC5, and MT1-MMP. Some pro-MMP-2 activation was found in macrophages, but pro-MMP-2 level or activation was not enhanced after stimulation with the proinflammatory mediators tumor necrosis factor-{alpha} or lipopolysaccharide. However, culturing of macrophages in conditioned medium from serum-starved vascular smooth muscle cells, which constitutively secrete pro-MMP-2, resulted in a strong pro-MMP-2 activation. Inhibition of furin-like PCs with the specific pharmacological inhibitor decanoyl-RVKR-chloromethylketone (dec-CMK) inhibited MT1-MMP activation in macrophages. Dec-CMK or furin-specific small interfering RNA significantly inhibited macrophage MT1-MMP–dependent activation of vascular smooth muscle cell–derived pro-MMP-2. Flow cytometry demonstrated that human circulating monocytes express furin and PC5, and MT1-MMP and immunohistochemistry revealed their colocalization in macrophages in advanced human atherosclerotic lesions.

Conclusions— Furin-like PCs (furin and PC5) play a central role in a MT-MMP–MMP-2 proteolytic cascade, involving provision of macrophage MT1-MMP for the activation of pro-MMP-2 synthesized by other cells. Furin and PC5 are expressed in human peripheral blood mononuclear cells and colocalize with MT1-MMP in macrophages in the atherosclerotic plaque, supporting the hypothesis that they are potential targets in atherosclerosis.


Key Words: metalloproteinases • atherosclerosis • inflammation • proprotein convertases




This article has been cited by other articles:


Home page
EndocrinologyHome page
R.-N. Chen, Y.-H. Huang, Y.-C. Lin, C.-T. Yeh, Y. Liang, S.-L. Chen, and K.-H. Lin
Thyroid Hormone Promotes Cell Invasion through Activation of Furin Expression in Human Hepatoma Cell Lines
Endocrinology, August 1, 2008; 149(8): 3817 - 3831.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
Y. Yang, N. Lu, J. Zhou, Z.-n. Chen, and P. Zhu
Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis
Rheumatology, June 21, 2008; (2008) ken225v1.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. J. Lockwood, C. Oner, Y. H. Uz, U. A. Kayisli, S. J. Huang, L. F. Buchwalder, W. Murk, E. F. Funai, and F. Schatz
Matrix Metalloproteinase 9 (MMP9) Expression in Preeclamptic Decidua and MMP9 Induction by Tumor Necrosis Factor Alpha and Interleukin 1 Beta in Human First Trimester Decidual Cells
Biol Reprod, June 1, 2008; 78(6): 1064 - 1072.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. Schneider, G. K. Sukhova, M. Aikawa, J. Canner, N. Gerdes, S.-M. T. Tang, G.-P. Shi, S. S. Apte, and P. Libby
Matrix Metalloproteinase-14 Deficiency in Bone Marrow-Derived Cells Promotes Collagen Accumulation in Mouse Atherosclerotic Plaques
Circulation, February 19, 2008; 117(7): 931 - 939.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
K. Mitko, S. E Ulbrich, H. Wenigerkind, F. Sinowatz, H. Blum, E. Wolf, and S. Bauersachs
Dynamic changes in messenger RNA profiles of bovine endometrium during the oestrous cycle
Reproduction, February 1, 2008; 135(2): 225 - 240.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Mayer, J. Hamelin, M.-C. Asselin, A. Pasquato, E. Marcinkiewicz, M. Tang, S. Tabibzadeh, and N. G. Seidah
The Regulated Cell Surface Zymogen Activation of the Proprotein Convertase PC5A Directs the Processing of Its Secretory Substrates
J. Biol. Chem., January 25, 2008; 283(4): 2373 - 2384.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. G. Spinale
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
Physiol Rev, October 1, 2007; 87(4): 1285 - 1342.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. S. Spruill, A. S. Lowry, R. E. Stroud, C. E. Squires, I. M. Mains, E. C. Flack, C. Beck, J. S. Ikonomidis, A. J. Crumbley, P. J. McDermott, et al.
Membrane-type-1 matrix metalloproteinase transcription and translation in myocardial fibroblasts from patients with normal left ventricular function and from patients with cardiomyopathy
Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1362 - C1373.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Fischoeder, H. Meyborg, D. Stibenz, E. Fleck, K. Graf, and P. Stawowy
Insulin augments matrix metalloproteinase-9 expression in monocytes
Cardiovasc Res, March 1, 2007; 73(4): 841 - 848.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Nagase, R. Visse, and G. Murphy
Structure and function of matrix metalloproteinases and TIMPs
Cardiovasc Res, February 15, 2006; 69(3): 562 - 573.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. P.G. Sluijter, D. P.V. de Kleijn, and G. Pasterkamp
Vascular remodeling and protease inhibition-bench to bedside
Cardiovasc Res, February 15, 2006; 69(3): 595 - 603.
[Abstract] [Full Text] [PDF]